Mordasini R, Grandjean E M, Nobile P C, Paumgartner G, Riva G
Schweiz Med Wochenschr. 1979 Aug 18;109(31):1140-3.
18 patients with primary hyperlipoproteinemia of type IIa and type IIb, on regularly controlled dietary treatment for 6 months and a 4 weeks placebo period, were given 300 mg procetofene per day for 12 weeks. The subjective tolerance of the drug was good. The serum triglyceride levels were lowered by about 35%, total cholesterol by 15%, LDL-cholesterol by 12% and Apo B by 20%. The HDL-cholesterol values remained unchanged. A slight increase in SGPT values indicates that liver function should be regularly checked in patients undergoing procetofene therapy.
18例IIa型和IIb型原发性高脂蛋白血症患者,在进行了6个月的常规饮食控制治疗和4周的安慰剂期后,每天给予300毫克普罗赛芬,持续12周。该药物的主观耐受性良好。血清甘油三酯水平降低了约35%,总胆固醇降低了15%,低密度脂蛋白胆固醇降低了12%,载脂蛋白B降低了20%。高密度脂蛋白胆固醇值保持不变。谷丙转氨酶值略有升高表明,接受普罗赛芬治疗的患者应定期检查肝功能。